Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133952) titled 'A Multicenter Phase II Clinical Trial of Sequential, Pulsed Administration of Teriflunomide, Decitabine and Lisaftoclax for Myelodysplastic Neoplasms with TP53 Multi-hit' on Oct. 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Condition:
Myelodysplastic Neoplasms
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-10-09
Target Sample Size: Experimental group:83;
Countries of Recruitment:
China
To know more, visit https://www.chict...